FDA Approves Deflazacort Supplement Application by Upsher Smith Labs
The FDA has approved a supplemental application for Deflazacort submitted by Upsher Smith Labs.
Asset / Drug
Drug and asset intelligence for Deflazacort with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.